3 responses to “Mineralocorticoid Receptor Antagonists in Heart Failure with Preserved Ejection Fraction: The TOPCAT and ALDO-DHF trials”

  1. Interesting article, but clinical benefit seems small.

  2. This adds more evidence, but further studies are needed.

  3. I find it very informative but still more studies should be done.

Leave a Reply